Latest News
Envision Healthcare Corporation has announced its acquisition by global investment firm KKR.
As a result of the completion of the merger, Envision has become a wholly owned subsidiary of funds affiliated with KKR, and Envision stockholders will receive an amount in cash equal to USD46.00 per share of Envision common stock.
As a result of the completion of the merger, shares of Envision’s common stock ceased trading on the NYSE prior to the opening of the NYSE today.
Mayfair-based alternative finance house IW Capital has invested GBP2 million in Eos Leisure, which manufactures and sells its own branded eliquid products (Vapemate, Soda Steam, Directors Cut) into the UK vaping market and provides manufacturing and scientific testing services for other suppliers in vaping and other markets.
The EIS qualifying investment of GBP2 million will be used to support the company’s growth, with a focus on building sales and marketing resources, continuing scientific accreditation work and product development.
In a regulated industry, Eos Leisure has made substantial capital investments in plant & equipment to build fully compliant, high capacity
Catalina Holdings (Bermuda) Ltd (Catalina) announces that it has closed a USD700 million equity capital raise and concluded its shareholder restructuring following receipt of regulatory approvals.
Following completion of this transaction, affiliates of Apollo Global Management, together with its consolidated subsidiaries, have become majority shareholders of Catalina, with RenaissanceRe Holdings Limited becoming a minority shareholder alongside Catalina’s management. As part of the shareholder restructuring, the Apollo Funds have committed an additional USD700 million in new equity capital to fund Catalina’s continued growth. Together with existing committed and undrawn equity, this brings Catalina’s total committed and undrawn equity to USD850 million.
Private equity firm Advent International has invested in Manjushree Technopack Ltd, India’s largest rigid plastic packaging solution provider, in partnership with the founding Kedia family.
As part of the transaction, Advent purchased all the shares owned by Kedaara Capital and a portion of the Kedia family’s stake in Manjushree Technopack.
Manjushree’s Founder and Managing Director, Vimal Kedia, and the rest of the company’s senior management team will remain closely involved in the business. Financial terms of the transaction were not disclosed.
Manjushree Technopack is the No1 manufacturer of rigid plastic packaging for the fast-moving consumer goods (FMCG) industry
New York-based private investment firm Greenbriar Equity Grouphas invested in vehicle intelligence company Spireon.
With over USD3.5 billion in capital and investments in the global transportation and logistics industries, Greenbriar becomes the primary investor in Spireon as a result of the transaction.
“Spireon is the leader in vehicle analytics and telematics solutions in the US, with a strong foothold in the automotive and commercial transportation sectors, which makes the company a natural fit with our portfolio of transportation and logistics companies,” says Michael Weiss, Managing Director at Greenbriar. “We look forward to working with the outstanding team at Spireon
Kainos Capital (Kainos), a food and consumer-focussed private equity firm, has agreed to sell its portfolio company SlimFast to Glanbia plc in a transaction valued at USD350 million. The transaction also includes SlimFast’s sister company, HNS.
Headquartered in Palm Beach Gardens, Florida, SlimFast is a leading provider of nutritional products, including clinically proven weight management and health and wellness products. The brand today enjoys 98 per cent consumer awareness with a broad offering of meal replacement beverages and snacks. Kainos acquired SlimFast from Unilever in 2014.
Andrew Rosen, Managing Partner of Kainos, says: “Our acquisition of SlimFast came with
Edinburgh-based venture capital firm Par Equity has invested GBP1.3m in a rapidly growing stem-cell research company that is helping pharmaceutical giants to develop new treatments for diseases including Parkinson’s and Alzheimer’s.
Censo Biotechnologies, which employs teams in Edinburgh and Cambridge, provides drug discovery services to some of the best known pharmaceutical and biotech companies in Europe, the US and Japan.
The company is a leader in technology to produce stem cells in a laboratory from a person’s skin or blood sample, which are then transformed into brain and other types of cell for drug research. It has a rapidly
Piper Jaffray Companies has held the final close of Piper Jaffray Merchant Banking Fund II, a USD130 million growth equity fund.
With the closing of Fund II, Piper Jaffray Merchant Banking manages USD275 million of committed and invested capital through Fund II and its two prior growth equity funds.
Fund II will invest in commercial-stage businesses with strong growth prospects within industry sectors covered by Piper Jaffray equity research and investment banking. Fund II plans to make senior equity and equity-linked investments of up to USD15 million per company. Focus sectors include healthcare, technology, business services, financial technology and
Vinson & Elkins continues to expand its global corporate practice with the addition of leveraged finance partner Lucy Jenkins in London.
Jenkins was previously with Simpson Thacher & Bartlett. She is the second partner in as many months to join V&E’s internationally recognised Leveraged Finance group in London, following the addition of Noel Hughes in September.
Jenkins joins a growing team of corporate partners in V&E’s London office. In addition to Hughes, recent arrivals include Paul Simcock in January and John Dawson and Federico Fruhbeck, who came on board in late 2017.
Operating one of the oldest London offices
By Amanda Daly, EzeCastle Integration – When confronted with unexpected business disruptions, alternative investment firms must react swiftly, methodically and successfully or else risk significant financial loss. This level of response requires extensive business continuity planning to ensure allspects of a firm’s business are evaluated and protected. In this blog, we will help you create a Business Continuity Plan and help you identify which threats pose a risk to your firm.
1. Regulatory review and landscape
The first step to creating an Business Continuity Plan is to perform a Regulatory Review as all businesses have requirements coming from oversight bodies. There are also
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
